5,975 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Orion Portfolio Solutions LLC

Orion Portfolio Solutions LLC acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,975 shares of the company’s stock, valued at approximately $260,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Farther Finance Advisors LLC lifted its holdings in shares of Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Morse Asset Management Inc bought a new position in Doximity during the 3rd quarter valued at approximately $46,000. Blue Trust Inc. raised its stake in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after buying an additional 1,193 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after acquiring an additional 412 shares in the last quarter. Finally, Quarry LP grew its stake in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after acquiring an additional 131,253 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Trading Up 5.7 %

Shares of DOCS stock opened at $55.18 on Friday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75. The stock has a market cap of $10.30 billion, a P/E ratio of 63.43, a P/E/G ratio of 4.16 and a beta of 1.40. The company has a 50 day simple moving average of $48.82 and a two-hundred day simple moving average of $38.57.

Analysts Set New Price Targets

Several research firms have recently issued reports on DOCS. Robert W. Baird lifted their price target on Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 17th. Wells Fargo & Company raised shares of Doximity from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $19.00 to $41.00 in a report on Friday, November 8th. KeyCorp upgraded shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price target on the stock in a report on Friday, November 8th. The Goldman Sachs Group assumed coverage on shares of Doximity in a report on Friday, November 15th. They issued a “neutral” rating and a $58.00 price objective for the company. Finally, Mizuho assumed coverage on Doximity in a research note on Wednesday, December 4th. They set a “neutral” rating and a $55.00 target price on the stock. Twelve investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $52.44.

Read Our Latest Research Report on Doximity

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.